Chemical Name: N-[(1S)-2-Methyl-1-[[(2S)-2-[5-[4’-[2-[(2S)-2-pyrrolidinyl]-1H-imidazol-5-yl][1,1’-biphenyl]-4-yl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]propyl]carbamic Acid Methyl Ester
Smiles: O=C(N1[C@H](C2=NC=C(C3=CC=C(C4=CC=C(C5=CN=C([C@@H]6CCCN6)N5)C=C4)C=C3)N2)CCC1)[C@H](C(C)C)NC(OC)=O
Inchi: InChI=1S/C34H42FN6O3/c1-22-26(33(42)39-15-5-3-7-30(39)36-22)13-19-41(20-14-27-23(2)37-31-8-4-6-16-40(31)34(27)43)17-11-24(12-18-41)32-28-10-9-25(35)21-29(28)44-38-32/h9-10,21,24H,3-8,11-20H2,1-2H3/q+1
A validated stability-indicating reverse-phase high-performance liquid chromatography method for daclatasvir, identification and characterization of degradation products using LC-ESI-QTOF-MS
By Warghade, Snehal V.; Bothara, Kailash G.
From Asian Journal of Pharmaceutical and Clinical Research (2019), 12(5), 302-308
Development and validation of HPLC fluorescence and UPLC/DAD stability-indicating methods for determination of hepatitis C antiviral agent daclatasvir
By Kamal, Andra H.; Ismail, Nahla S.; Mabroijk, Mokhtar M.; Bebawy, Lories I.; Mekky, Mai A.
From Journal of AOAC International (2019), 102(4), 1125-1131
A stability-indicating UPLC method for the determination of potential impurities and its mass by a new QDa mass detector in daclatasvir drug used to treat hepatitis C infection
By Jagadabi, Varaprasad; Kumar, P. V. Nagendra; Mahesh, Kasthuri; Pamidi, Srinivasu; Ramaprasad, L. A.; Nagaraju, D.
From Journal of Chromatographic Science (2019), 57(1), 44-53